172 related articles for article (PubMed ID: 36797535)
21. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
[No Abstract] [Full Text] [Related]
22. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
[TBL] [Abstract][Full Text] [Related]
23. "Preemptive" live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case report.
Fouzas I; Sotiropoulos GC; Molmenti EP; Beckebaum S; Schmitz KJ; Broelsch CE; Lang H; Malagó M
Transplant Proc; 2008 Dec; 40(10):3806-7. PubMed ID: 19100497
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
25. Impact of treatment modalities on patients with recurrent hepatocellular carcinoma after liver transplantation: Preliminary experience.
Yang Z; Wang S; Tian XY; Xie QF; Zhuang L; Li QY; Chen CZ; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):365-370. PubMed ID: 32553774
[TBL] [Abstract][Full Text] [Related]
26. Systematic review of outcomes and meta-analysis of risk factors for prognosis after liver resection for hepatocellular carcinoma without cirrhosis.
Xie QS; Chen ZX; Zhao YJ; Gu H; Geng XP; Liu FB
Asian J Surg; 2021 Jan; 44(1):36-45. PubMed ID: 32988708
[TBL] [Abstract][Full Text] [Related]
27. Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study.
Sempokuya T; Forlemu A; Azawi M; Silangcruz K; Khoury N; Ma J; Wong LL
World J Clin Oncol; 2022 May; 13(5):352-365. PubMed ID: 35662983
[TBL] [Abstract][Full Text] [Related]
28. Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.
Kim YJ; Rhee H; Yoo JE; Alves VAF; Kim GJ; Kim HM; Herman P; Chagas A; Kim H; Park YN
Histopathology; 2017 Aug; 71(2):217-226. PubMed ID: 28326574
[TBL] [Abstract][Full Text] [Related]
29. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
30. Curative lung metastectomy and complete pathological response after neo-adjuvant GEMOX chemotherapy for relapse fibrolamellar hepatocellular carcinoma.
Eng JY; Soon SY; Winnie Ling HY
Med J Malaysia; 2018 Feb; 73(1):46-48. PubMed ID: 29531203
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in fibrolamellar hepatocellular carcinoma in young people.
Darcy DG; Malek MM; Kobos R; Klimstra DS; DeMatteo R; La Quaglia MP
J Pediatr Surg; 2015 Jan; 50(1):153-6. PubMed ID: 25598114
[TBL] [Abstract][Full Text] [Related]
32. Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion.
Zhang H; Yuan SX; Dai SY; Zhang JM; Huang X; Lu CD; Lu JH; Wu FQ; Lau WY; Wu MC; Yang T; Shen F
World J Surg; 2014 Apr; 38(4):947-57. PubMed ID: 24258262
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of prognostic factors after curative resection for combined hepatocellular and cholangiocarcinoma].
Kim W; Lee JH; Kim YJ; Yoon JH; Suh KS; Lee KU; Jang JJ; Lee HS
Korean J Gastroenterol; 2007 Mar; 49(3):158-65. PubMed ID: 18172344
[TBL] [Abstract][Full Text] [Related]
34. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
[TBL] [Abstract][Full Text] [Related]
35. Prognosis and results after resection of very large (>or=10 cm) hepatocellular carcinoma.
Shah SA; Wei AC; Cleary SP; Yang I; McGilvray ID; Gallinger S; Grant DR; Greig PD
J Gastrointest Surg; 2007 May; 11(5):589-95. PubMed ID: 17393258
[TBL] [Abstract][Full Text] [Related]
36. Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.
de'Angelis N; Landi F; Carra MC; Azoulay D
World J Gastroenterol; 2015 Oct; 21(39):11185-98. PubMed ID: 26494973
[TBL] [Abstract][Full Text] [Related]
37. Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis.
Lim C; Shinkawa H; Hasegawa K; Bhangui P; Salloum C; Gomez Gavara C; Lahat E; Omichi K; Arita J; Sakamoto Y; Compagnon P; Feray C; Kokudo N; Azoulay D
Liver Transpl; 2017 Dec; 23(12):1553-1563. PubMed ID: 28945955
[TBL] [Abstract][Full Text] [Related]
38. Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.
Lee HW; Choi GH; Kim DY; Park YN; Kim KS; Choi JS; Ahn SH; Han KH
Oncology; 2017; 93(4):224-232. PubMed ID: 28571030
[TBL] [Abstract][Full Text] [Related]
39. Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases.
Chagas AL; Kikuchi L; Herman P; Alencar RS; Tani CM; Diniz MA; Pugliese V; Rocha Mde S; D'Albuquerque LA; Carrilho FJ; Alves VA
Clinics (Sao Paulo); 2015 Mar; 70(3):207-13. PubMed ID: 26017653
[TBL] [Abstract][Full Text] [Related]
40. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
